Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · IEX Real-Time Price · USD
29.36
+0.54 (1.87%)
At close: Mar 28, 2024, 4:00 PM
30.99
+1.63 (5.55%)
After-hours: Mar 28, 2024, 7:50 PM EDT

Jasper Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Cash & Equivalents
87.338.6785.0520.1827.16
Cash & Cash Equivalents
87.338.6785.0520.1827.16
Cash Growth
125.78%-54.53%321.37%-25.70%-
Receivables
00.6600.60
Other Current Assets
1.632.42.79-0.10
Total Current Assets
88.9441.7387.8320.6927.16
Property, Plant & Equipment
4.195.454.832.030
Other Long-Term Assets
1.761.180.990.640.05
Total Long-Term Assets
5.956.635.822.670.05
Total Assets
94.8948.3693.6523.3627.21
Accounts Payable
4.151.773.921.420.62
Current Debt
0.970.870.5100
Other Current Liabilities
7.254.433.62.61.37
Total Current Liabilities
12.377.078.024.011.99
Long-Term Debt
1.812.792.381.620
Other Long-Term Liabilities
2.262.5213.749.014.12
Total Long-Term Liabilities
4.085.3116.1210.644.12
Total Liabilities
16.4512.3724.1414.656.11
Total Debt
2.793.652.891.620
Debt Growth
-23.69%26.55%77.65%--
Retained Earnings
-169.6-105.14-67.45-36.81-5.14
Shareholders' Equity
78.4435.9969.52-35.13-4.73
Net Cash / Debt
84.5235.0282.1618.5627.16
Net Cash / Debt Growth
141.37%-57.38%342.70%-31.68%-
Net Cash Per Share
8.109.6072.1130.3060.22
Working Capital
76.5634.6779.8116.6725.17
Book Value Per Share
7.519.8761.01-57.35-10.49
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).